134 related articles for article (PubMed ID: 18593363)
1. Hyperthermia and fibrinolytic therapy do not improve the beneficial effect of radioimmunotherapy following cytoreductive surgery in rats with peritoneal carcinomatosis of colorectal origin.
Aarts F; Hendriks T; Boerman OC; Oyen WJ; Bleichrodt RP
Cancer Biother Radiopharm; 2008 Jun; 23(3):301-9. PubMed ID: 18593363
[TBL] [Abstract][Full Text] [Related]
2. A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.
Aarts F; Hendriks T; Boerman OC; Koppe MJ; Oyen WJ; Bleichrodt RP
Ann Surg Oncol; 2007 Nov; 14(11):3274-82. PubMed ID: 17653591
[TBL] [Abstract][Full Text] [Related]
3. The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat.
Aarts F; Bleichrodt RP; de Man B; Lomme R; Boerman OC; Hendriks T
Ann Surg Oncol; 2008 Nov; 15(11):3299-307. PubMed ID: 18712445
[TBL] [Abstract][Full Text] [Related]
4. Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal origin.
Aarts F; Koppe MJ; Hendriks T; van Eerd JE; Oyen WJ; Boerman OC; Bleichrodt RP
Ann Surg Oncol; 2007 Feb; 14(2):533-40. PubMed ID: 17122992
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis.
Koppe MJ; Hendriks T; Boerman OC; Oyen WJ; Bleichrodt RP
J Nucl Med; 2006 Nov; 47(11):1867-74. PubMed ID: 17079821
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative versus early postoperative intraperitoneal chemotherapy after cytoreduction for colorectal peritoneal carcinomatosis: an experimental study.
Klaver YL; Hendriks T; Lomme RM; Rutten HJ; Bleichrodt RP; de Hingh IH
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S475-82. PubMed ID: 21837528
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model.
Klaver YL; Hendriks T; Lomme RM; Rutten HJ; Bleichrodt RP; de Hingh IH
Br J Surg; 2010 Dec; 97(12):1874-80. PubMed ID: 20806291
[TBL] [Abstract][Full Text] [Related]
8. Can antibody galactosylation be used to improve radioimmunotherapy of induced peritoneal carcinomatosis of colonic origin in the rat?
Aarts F; Hendriks T; Eek A; Oyen WJ; Bleichrodt RP; Boerman OC
Cancer Biother Radiopharm; 2009 Feb; 24(1):29-34. PubMed ID: 19243245
[TBL] [Abstract][Full Text] [Related]
9. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Braam HJ; van Oudheusden TR; de Hingh IH; Nienhuijs SW; Boerma D; Wiezer MJ; van Ramshorst B
J Surg Oncol; 2014 Jun; 109(8):841-7. PubMed ID: 24619813
[TBL] [Abstract][Full Text] [Related]
10. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
11. Cytoreduction and hyperthermic intraperitoneal chemotherapy: a feasible and effective option for colorectal cancer patients after emergency surgery in the presence of peritoneal carcinomatosis.
van Oudheusden TR; Braam HJ; Nienhuijs SW; Wiezer MJ; van Ramshorst B; Luyer MD; Lemmens VE; de Hingh IH
Ann Surg Oncol; 2014 Aug; 21(8):2621-6. PubMed ID: 24671638
[TBL] [Abstract][Full Text] [Related]
12. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Iversen LH; Rasmussen PC; Laurberg S
Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824
[TBL] [Abstract][Full Text] [Related]
13. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermia and intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis: an experimental study.
Klaver YL; Hendriks T; Lomme RM; Rutten HJ; Bleichrodt RP; de Hingh IH
Ann Surg; 2011 Jul; 254(1):125-30. PubMed ID: 21502859
[TBL] [Abstract][Full Text] [Related]
15. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal and appendiceal origin].
Berger Y; Zbar AP; Lebedyev A; Levi Y; Nevler A; Aderka D; Golan T; Purim O; Brenner B; Natur M; Gutman M
Harefuah; 2014 Jun; 153(6):315-9, 368. PubMed ID: 25095601
[TBL] [Abstract][Full Text] [Related]
16. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.
Razenberg LG; van Gestel YR; Creemers GJ; Verwaal VJ; Lemmens VE; de Hingh IH
Eur J Surg Oncol; 2015 Apr; 41(4):466-71. PubMed ID: 25680955
[TBL] [Abstract][Full Text] [Related]
17. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer.
Franko J; Gusani NJ; Holtzman MP; Ahrendt SA; Jones HL; Zeh HJ; Bartlett DL
Ann Surg Oncol; 2008 Nov; 15(11):3065-72. PubMed ID: 18712450
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis.
Ceelen W; Van Nieuwenhove Y; Putte DV; Pattyn P
Ann Surg Oncol; 2014 Sep; 21(9):3023-8. PubMed ID: 24756812
[TBL] [Abstract][Full Text] [Related]
19. Urological procedures in patients with peritoneal carcinomatosis of colorectal cancer treated with HIPEC: morbidity and survival analysis.
Braam HJ; van Oudheusden TR; de Hingh IH; Nienhuijs SW; Boerma D; Wiezer MJ; van Ramshorst B
Anticancer Res; 2015 Jan; 35(1):295-300. PubMed ID: 25550563
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin.
Eveno C; Passot G; Goéré D; Soyer P; Gayat E; Glehen O; Elias D; Pocard M
Ann Surg Oncol; 2014 Jun; 21(6):1792-800. PubMed ID: 24337648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
